Dr. Reddy’s Laboratories announced the launch of Zoledronic Acid Injection, the generic version of Novartis‘ Zometa. Zometa is a bisphosphonate indicated for hypercalcemia of malignancy, and as ...

A new drug called denosumab may soon give Zometa (zoledronic acid) competition as the standard of care in treating bone metastases in patients with advanced breast cancer. Patients taking denosumab ...

Avenacy intros generic Zometa Zoledronic acid injection is indicated for the treatment of hypercalcemia of malignancy and for the treatment of multiple myeloma and bone metastases of solid tumors, in ...

March 30, 2005 ( updated April 5, 2005) — The U.S. Food and Drug Administration (FDA) approved in January revisions to safety labeling to advise healthcare professionals of the following changes: use ...

Hyderabad: Aurobindo Pharma Ltd became the latest Indian generic maker to get US Food and Drug Administration (USFDA) approval to launch zoledronic acid injection of 4 mg/5ml strength. The medicine, ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Zoledronic Acid Injection, USP in ...

EAST HANOVER, N.J., Dec. 11 /PRNewswire/ -- New data released today demonstrate that the addition of Zometa® (zoledronic acid) injection to standard chemotherapy before breast cancer surgery reduces ...

Zometa is indicated for the treatment for hypercalcemia of malignancy. It is also used to reduce and delay bone complications due to multiple myeloma and bone metastases from solid tumors. Zometa is ...